Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2023-10-16Clinical Trial Update: Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation [NA]
Clinical trial update on Mirena IUD's effect related to ovarian cell proliferation in epithelial ovarian cancer; results completed and poste…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial [Phase 2, Phase 3]
Trial update for intraperitoneal therapy with carboplatin in epithelial ovarian cancer and related conditions; the study has completed phase…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of a Wee-1 inhibitor (AZD1775/MK-1775) with carboplatin in p53-mutated, refractory/resistant epithe…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial comparing weekly versus every-3-weeks carboplatin plus paclitaxel in advanced epithelial ovarian cancer is completed.
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating whether sodium thiosulfate reduces nephrotoxicity from intraperitoneal cisplatin during heat-perfusion che…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies [Phase 2]
Phase 2 trial update for enzalutamide in AR-positive ovarian, fallopian tube, or primary peritoneal cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update investigating Abraxane with bevacizumab biosimilar in patients with recurrent, platinum-resistant epithelial ovarian ca…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients [Phase 2]
A Phase 2 clinical trial update on heated intraperitoneal chemotherapy for ovarian cancer, with unclear status.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer [Phase 3]
A single-arm Phase 3 trial of IMGN853 in Chinese adults with platinum-resistant epithelial ovarian cancer is ongoing, with conditions includ…
-
FDA approval · 2022-11-14FDA Approved: ELAHERE — Original Application (ImmunoGen, Inc.)
The FDA approved ELAHERE (mirvetuximab soravtansine) from ImmunoGen as the original approval for FRα-positive, platinum-resistant epithelial…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse [Phase 2]
Phase 2 clinical trial update for Tri Association in patients with advanced epithelial ovarian cancer in relapse (status unknown).
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer [Phase 4]
Phase 4 trial evaluating pegylated liposomal doxorubicin (PLD) plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab with or without CC-486 in platinum-resistant ovarian cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi [Phase 2]
Phase II trial evaluating niraparib and anlotinib as maintenance retreatment in platinum-sensitive recurrent ovarian cancer after prior PARP…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer. [Phase 3]
Phase 3 trial evaluating maintenance retreatment with olaparib in epithelial ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer [Phase 4]
Phase 4 clinical trial update of PARP inhibitor as oral maintenance in low-risk ovarian cancer is underway, status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: An Open Label Extension Study of the Efficacy of MORAb-003 [Phase 2]
Open-label extension study of MORAb-003 (epithelial ovarian cancer) in Phase 2 has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating chemotherapy, oregovomab, and nivolumab in patients with epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC [Phase 2]
Phase 2 clinical trial evaluating efficacy and safety of SG001 in combination with PLD for platinum-resistant relapsed epithelial ovarian ca…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) [Phase 2]
Phase 2 study ARIEL2 evaluating rucaparib in platinum-sensitive relapsed high-grade ovarian/fallopian tube/primary peritoneal cancer complet…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for DPX-Survivac in recurrent ovarian-related cancers, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) [Phase 2]
Phase 2 trial ARIES evaluating rucaparib with nivolumab in selected solid tumors has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 study evaluating oral gimatecan in platinum-resistant epithelial ovarian cancer and related abdominal cancers is ongoing with unknow…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Neoadjuvant Therapy for Ovarian Cancer [Phase 2]
Phase 2 neoadjuvant therapy trial for epithelial ovarian cancer with involvement of primary peritoneal cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer [Phase 2]
Phase 2 trial evaluating postoperative adjuvant chemotherapy with bevacizumab and maintenance bevacizumab following neoadjuvant therapy in e…